Cardiac natriuretic peptides are not merely passive biomarkers — they actively participate in cardiovascular pathophysiology through vasodilation, natriuresis, and neurohormonal suppression, making them both diagnostic tools and therapeutic targets.
Markers AND mediatorsNatriuretic peptides don't just measure heart failure — they fight it through vasodilation and hormone suppression, justifying therapies that boost them
What the researchers found
Natriuretic peptides serve dual roles as sensitive cardiac biomarkers AND active cardiovascular protectors, with evidence supporting both diagnostic utility and therapeutic potential through their vasodilatory, natriuretic, and neurohormonal-suppressive actions.
Why it matters
Understanding that natriuretic peptides are active protectors (not just markers) justifies therapies that boost them — the scientific basis for sacubitril/valsartan (Entresto).
How the study worked
Review synthesizing diagnostic/prognostic biomarker data with physiological/therapeutic evidence for natriuretic peptide cardiovascular effects.
What this study cannot tell us
The relative therapeutic contribution of boosted natriuretic peptides versus reduced angiotensin is still debated for drugs like Entresto.
How to read the evidence
Strong evidence from a comprehensive review integrating decades of diagnostic, physiological, and therapeutic research on natriuretic peptides.
When this study was published
Published in 2002. This dual-role concept was validated by Entresto's clinical success in boosting natriuretic peptides for heart failure treatment.
The bigger picture
The realization that biomarkers can also be therapeutic targets transformed cardiology. BNP isn't just telling us the heart is failing — it's trying to fix the problem. Boosting this natural defense (with Entresto) helps the heart heal.
Questions still open
- How much of Entresto's benefit comes from boosted natriuretic peptides versus reduced angiotensin?
- Could direct natriuretic peptide infusion outperform Entresto?
- Are there other biomarkers that are also active disease mediators?
Common questions
Is BNP just a blood test or does it actually do something?
Is this why Entresto works?
Read the original research
Pathophysiological and clinical relevance of circulating levels of cardiac natriuretic hormones: are they merely markers of cardiac disease?
Clinical chemistry and laboratory medicine, 40(8), 752-60
Citation
Clerico, Aldo. (2002). Pathophysiological and clinical relevance of circulating levels of cardiac natriuretic hormones: are they merely markers of cardiac disease?. Clinical chemistry and laboratory medicine, 40(8), 752-60.